A reduction in the expression of the TGF-β1 receptor (TGF-β1-R) is associated with an increase in the levels of TGF-β1 in the tumor microenviroment and abrogates the tumor-suppressive effects of TGF-β1 and the invasive phenotype in the majority of cases of BC. The gene discussed is TGFB1; the disease is breast cancer.